Published in the Journal of Perinatology, the study by Rumpel, Zaniletti, Stoops and colleagues focuses on neonates with CAKUT who are admitted to level IV neonatal intensive care units, the highest level of intensive care available for newborns. These units care for infants requiring advanced respiratory support, complex surgery, dialysis, continuous monitoring and other highly specialized treatments. The researchers set out to predict in-hospital mortality using perinatal factors—information available around the time of birth—rather than relying solely on complications that emerge later during a hospital stay.

The clinical challenge is substantial because CAKUT does not represent a single disease. It is an umbrella term covering kidney agenesis, renal dysplasia, obstructive abnormalities, urinary tract malformations and other developmental defects. Some infants have one abnormal kidney and remain relatively stable, while others have bilateral disease that severely limits renal function. Kidney failure can affect fluid balance, blood pressure, electrolyte concentrations and acid-base chemistry. In the newborn period, these disturbances may develop alongside respiratory failure, infection, cardiovascular instability or the need for urgent surgery, making early risk assessment particularly difficult.

The proposed calculator translates several perinatal characteristics into an individualized estimate of mortality risk. In medical prediction modeling, such a tool typically combines patient-level variables through a statistical algorithm. Each factor contributes a specific amount to the final prediction, allowing the model to transform a complex clinical profile into an interpretable probability. Depending on the variables selected by the investigators, the calculation may incorporate features such as gestational age, birth weight, sex, prenatal diagnosis, congenital conditions and the severity of illness at admission. The essential principle is that the estimate is generated from information available early enough to support decision-making.

A prediction model can be especially valuable in CAKUT because the first clinical decisions often must be made before the full anatomy and long-term prognosis are known. Neonatologists may need to determine how aggressively to stabilize an infant, whether transfer to a highly specialized center is necessary, how urgently nephrology or urology should be involved, and which families require immediate counseling. A calibrated risk estimate cannot replace clinical judgment, but it can provide a consistent framework for interpreting multiple risk factors at once. It may also help clinicians identify infants who appear more vulnerable than their initial physical examination suggests.

The study’s focus on level IV NICUs is important for another reason: these hospitals generally receive the most medically complex newborns, including infants referred from other facilities because of severe malformations or organ failure. Outcomes in such settings can be influenced by referral patterns, surgical capacity, access to pediatric nephrology and the availability of renal replacement therapies. A model built specifically for this population is therefore intended to reflect the realities of high-acuity neonatal care rather than the broader population of infants with CAKUT, many of whom never require intensive care.

An interactive calculator could make the research more accessible at the bedside. Instead of asking clinicians to interpret a table or manually apply regression coefficients, an online interface can allow them to enter a newborn’s characteristics and receive a calculated estimate almost immediately. Such tools can also reduce arithmetic errors and make the underlying model easier to use across hospitals. However, the reliability of any calculator depends on how well its predictions are validated in different populations. A model developed from one healthcare network or a particular group of intensive care patients may perform differently in another region, among different racial and ethnic populations or in hospitals with different treatment resources.

The researchers’ work also highlights the growing role of clinical prediction models in neonatal medicine. Modern neonatal care produces large quantities of structured information, from prenatal imaging and delivery-room events to laboratory measurements and organ-support requirements. Statistical models can identify patterns that are difficult to recognize when dozens of variables must be considered simultaneously. Yet technical performance is only one part of clinical usefulness. A successful tool must also be transparent, understandable, regularly updated and tested for calibration, meaning that predicted risks should correspond closely to outcomes observed in real patients.

For families, mortality estimates are emotionally sensitive and must be communicated with care. A probability is not a destiny, and no calculator can capture every factor influencing an individual infant’s course. Treatment decisions may change rapidly as kidney function evolves, surgery becomes possible or an infant responds to intensive care. The CAKUT calculator is best understood as an aid to structured assessment and shared decision-making, not as an automated verdict. Its greatest potential may lie in helping medical teams recognize risk early, coordinate multidisciplinary care and explain uncertainty more clearly during some of the most difficult conversations in neonatal medicine.

By targeting a population in which anatomy, physiology and critical illness intersect, the new tool aims to bring greater precision to the first days of life for infants with CAKUT. If externally validated and integrated responsibly into neonatal practice, it could support earlier consultation, improve communication between referring hospitals and tertiary centers, and provide researchers with a common framework for comparing outcomes. The calculator does not eliminate the complexity of congenital kidney disease, but it represents a step toward making that complexity more measurable—and potentially more manageable—when every hour can matter.

Subject of Research: Prediction of in-hospital mortality in neonates with congenital anomalies of the kidney and urinary tract admitted to level IV neonatal intensive care units.

Article Title: CAKUT calculator: a clinical risk prediction tool for in-hospital mortality in neonates with congenital anomalies of the kidney and urinary tract admitted to level IV NICUs

Article References: Rumpel, J.A., Zaniletti, I., Stoops, C. et al. “CAKUT calculator: a clinical risk prediction tool for in-hospital mortality in neonates with congenital anomalies of the kidney and urinary tract admitted to level IV NICUs.” Journal of Perinatology (2026). https://doi.org/10.1038/s41372-026-02823-6

Image Credits: AI Generated

DOI: 10.1038/s41372-026-02823-6

Keywords: CAKUT, congenital kidney anomalies, neonates, neonatal intensive care, in-hospital mortality, clinical risk prediction, NICU, kidney disease, neonatal medicine, risk calculator

The study harnesses a multicenter design encompassing an extensive dataset from level IV NICUs across North America, representing some of the sickest neonatal populations managed in the continent. By focusing on three principal infectious entities—bloodstream infections, urinary tract infections, and meningitis—it provides a panoramic view of pathogen prevalence, antimicrobial resistance patterns, and the intersection of bacterial and fungal etiologies. This comprehensive approach is critical, given that these infection types contribute disproportionately to the clinical decline of neonates, often resulting in prolonged hospital stays, increased antibiotic exposure, and higher mortality rates. The study’s findings challenge some longstanding assumptions about neonatal infection epidemiology, bringing to light nuanced variations in pathogen distribution across different NICUs, as well as emergent resistance profiles that complicate clinical management.

Bloodstream infections represent one of the most formidable challenges in NICUs due to their rapid onset and potential to cause systemic inflammatory responses that overwhelm neonatal physiology. Nishihara and colleagues documented not just the incidence rates of BSI but delved into the microbiological landscape in striking detail. Gram-positive cocci, including coagulase-negative staphylococci, dominate the bloodstream infection panorama, reaffirming their role as critical neonatal pathogens. However, the study also identified a noteworthy prevalence of Gram-negative organisms, such as Klebsiella species and Escherichia coli, whose increasing resistance traits underscore the urgent need for vigilant antibiotic stewardship and innovative treatment modalities. The interface of these bacterial pathogens with invasive devices and central lines, frequently employed in level IV NICUs, remains a focal point of infection control efforts.

Urinary tract infections in neonates, although clinically subtler than bloodstream infections, pose a significant threat by acting as reservoirs for invasive pathogens and potential precursors to systemic spread. The study’s meticulous analysis elucidates an intricate relationship between urinary pathogens and the broader infection ecology within NICUs. Notably, fungi, particularly Candida species, emerge as significant contributors to UTIs in this population, revealing the multifaceted nature of neonatal infections. This fungal involvement, often overshadowed in neonatal infection research, demands heightened clinical vigilance and perhaps a reevaluation of antifungal prophylaxis protocols, especially in units witnessing elevated Candida incidence.

Meningitis in neonates represents a critically dangerous condition characterized by inflammation of the protective membranes surrounding the brain and spinal cord, often leading to dire neurological outcomes. Nishihara et al. provide a compelling synthesis of meningitis cases across the participating NICUs, highlighting the predominance of bacterial etiologies alongside a concerning, albeit smaller, representation of fungal meningitis. The study underscores the complexity of diagnosis in this cohort, where clinical signs are frequently non-specific, and laboratory confirmation can be delayed or inconclusive. This diagnostic challenge underscores the vital importance of rapid, sensitive, and specific molecular assays to facilitate timely intervention, a gap that modern NICUs must urgently address.

One of the hallmark contributions of this investigation lies in its in-depth evaluation of antimicrobial resistance patterns across diverse causative agents. The rise of multidrug-resistant organisms (MDROs) portends grave treatment challenges, particularly in neonatal populations where therapeutic options are already limited by toxicity profiles and developmental considerations. The researchers decoded resistance mechanisms prevalent in Gram-negative rods, including extended-spectrum beta-lactamase (ESBL) production and carbapenem resistance, which severely restrict treatment efficacy. Moreover, the persistence of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) within NICU environments further complicates therapeutic landscapes, demanding both aggressive infection control and novel antimicrobial development.

Fungal infections add an additional layer of complexity, as the study vividly illustrates. Neonates, especially those with low birth weights or prolonged NICU stays, are particularly susceptible to invasive candidiasis. The researchers’ data illuminate not only the prevalence but also species distribution, revealing shifts towards non-albicans Candida species, which often exhibit reduced susceptibility to first-line antifungal agents. This evolutionary dynamic spotlights an urgent need for ongoing mycological surveillance and the adaptation of empiric antifungal treatment protocols to local epidemiology, to optimize outcomes and curtail mortality rates.

Nishihara et al.’s study did not overlook the critical influence of neonatal host factors and clinical practices on infection risk. Prematurity, invasive device utilization, prolonged antibiotic therapy, and immunological immaturity jointly orchestrate a high-risk milieu that fosters pathogen invasion and persistence. Detailed patient-level data analyses reinforced that customized infection prevention strategies tailored to individual risk profiles are paramount. This precision approach could inform targeted probiotics, stringent catheter care bundles, and antibiotic cycling protocols that curtail resistance development.

In refining understanding of microbial dynamics, the study leveraged state-of-the-art genomic sequencing and rapid diagnostic platforms, offering real-time insights into pathogen evolution and transmission pathways within NICU settings. These technological innovations enable infection control teams to trace outbreaks with unprecedented accuracy, implementing timely containment measures. The intersection of genomics with clinical epidemiology heralds a new era in neonatal infection management, potentially transforming reactive paradigms into predictive prevention.

Furthermore, the regional variations noted across the myriad level IV NICUs underscore the influence of local ecology, institutional practices, and patient demographics in shaping infection profiles. The study advocates for the establishment of standardized surveillance frameworks across NICU networks, facilitating data sharing, benchmarking, and communal learning. Such collaborative infrastructures could accelerate identification of emerging threats and dissemination of best practices, ultimately elevating neonatal care standards continent-wide.

Beyond clinical implications, the economic ramifications revealed are profound. Prolonged hospital stays driven by infection-related complications inflate healthcare costs substantially. By quantifying this burden, Nishihara et al. present a compelling argument for intensified resource allocation towards infection prevention programs, staff education, and infrastructure improvements, positing that investment in these areas can yield significant cost savings and enhanced patient outcomes.

Crucially, the psychosocial impact on families grappling with neonatal infections in critical care settings cannot be overstated. Lengthened hospitalizations, procedural interventions, and uncertain prognoses exact a heavy toll on parental mental health and family dynamics. The study’s comprehensive epidemiological data provide a foundation for crafting supportive policies that address these dimensions, integrating family-centered care with rigorous clinical management.

In summation, the groundbreaking work of Nishihara and colleagues opens an essential window into the complex bacterial and fungal infectious landscape of level IV NICUs across North America. Through their meticulous epidemiological dissection, the study unveils both persistent challenges and emerging threats, while charting a forward-looking path anchored in precision medicine, innovative diagnostics, antimicrobial stewardship, and collaborative surveillance. The implications for neonatology are profound, promising not only to reduce infection burden but also to enhance overall survival and quality of life for the tiniest patients.

As neonatal care continues to evolve within the broader context of antimicrobial resistance and healthcare-associated infections, studies such as this are pivotal. They recalibrate clinical focus, catalyze research innovation, and inform policy formulation, collectively contributing to a future where neonatal infections are no longer a dominant source of morbidity and mortality. Nishihara et al.’s contribution resonates as a clarion call for the neonatology community and allied healthcare disciplines to harness data-driven insights, embrace cutting-edge technologies, and foster multidisciplinary collaboration in the ongoing battle against neonatal infections.

Subject of Research: Epidemiology of bacterial and fungal infections in level IV neonatal intensive care units (NICUs) across North America, specifically focusing on bloodstream infections, urinary tract infections, and meningitis.

Article Title: Epidemiology of bacterial and fungal infections among level IV neonatal units in North America

Article References:
Nishihara, Y., Zaniletti, I., Zenge, J. et al. Epidemiology of bacterial and fungal infections among level IV neonatal units in North America. J Perinatol (2025). https://doi.org/10.1038/s41372-025-02337-7

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41372-025-02337-7